Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Toronto - Delayed Quote CAD

Healwell AI Inc. (AIDX.TO)

Compare
1.4700
-0.0400
(-2.65%)
At close: April 1 at 4:00:00 PM EDT
Loading Chart for AIDX.TO
  • Previous Close 1.5100
  • Open 1.5300
  • Bid 1.4700 x --
  • Ask 1.4900 x --
  • Day's Range 1.4400 - 1.5300
  • 52 Week Range 0.9350 - 3.2600
  • Volume 151,867
  • Avg. Volume 421,724
  • Market Cap (intraday) 289.12M
  • Beta (5Y Monthly) -1.01
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1900
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.93

Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care. It offers AI-enabled decision support platform for healthcare providers. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in October 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.

www.healwell.ai

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AIDX.TO

View More

Performance Overview: AIDX.TO

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

AIDX.TO
27.59%
S&P/TSX Composite index (^GSPTSE)
1.68%

1-Year Return

AIDX.TO
58.06%
S&P/TSX Composite index (^GSPTSE)
12.84%

3-Year Return

AIDX.TO
5.00%
S&P/TSX Composite index (^GSPTSE)
14.03%

5-Year Return

AIDX.TO
69.94%
S&P/TSX Composite index (^GSPTSE)
94.41%

Compare To: AIDX.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AIDX.TO

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    289.12M

  • Enterprise Value

    301.91M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.11

  • Price/Book (mrq)

    4.47

  • Enterprise Value/Revenue

    7.75

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -65.34%

  • Return on Assets (ttm)

    -23.60%

  • Return on Equity (ttm)

    -56.08%

  • Revenue (ttm)

    38.97M

  • Net Income Avi to Common (ttm)

    -25.41M

  • Diluted EPS (ttm)

    -0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.41M

  • Total Debt/Equity (mrq)

    30.25%

  • Levered Free Cash Flow (ttm)

    -2.09M

Research Analysis: AIDX.TO

View More

Company Insights: AIDX.TO

Research Reports: AIDX.TO

View More

People Also Watch